Negative regulation of bcl-2 expression by p53 in hematopoietic cells

被引:0
|
作者
Yu-ling Wu
John W Mehew
Caroline A Heckman
Magdalena Arcinas
Linda M Boxer
机构
[1] The Center for Molecular Biology in Medicine,Palo Alto Veterans Affairs Medical Center and the Department of Medicine
[2] Stanford University School of Medicine,undefined
来源
Oncogene | 2001年 / 20卷
关键词
lymphoma; transcription; p53;
D O I
暂无
中图分类号
学科分类号
摘要
The p53 protein activates promoters containing p53 binding sites, and it represses other promoters. We examined the effect of p53 on bcl-2 expression in both the DHL-4 B cell line and the K562 erythroleukemia line. Transient transfection analyses revealed that wild-type p53 repressed the bcl-2 full-length promoter. The region of the bcl-2 promoter that was responsive to p53 was mapped to the bcl-2 P2 minimal promoter region, and we showed that p53 and the TATA binding protein bound to the bcl-2 TATA sequence. The TATA binding protein, p53, histone deacetylase-1 and mSin3a could be co-immunoprecipitated from K562 cell nuclear extract. The TATA binding protein and mSin3a could be recovered in a complex at the bcl-2 promoter TATA sequence, however, the formation of this complex was not dependent on the presence of p53. Treatment of K562 cells with the histone deacetylase inhibitor, trichostatin A, resulted in an increase in bcl-2 promoter activity whether p53 was present or not. Therefore, we demonstrated that p53 and the histone deacetylases repress the bcl-2 promoter independently. Similar results were obtained when endogenous bcl-2 mRNA or protein levels were measured in response to either p53 or trichostatin A, and p53 expression resulted in enhanced apoptosis. RNase protection assays demonstrated that transcription from the endogenous 3′ bcl-2 promoter was decreased by p53. The regions of p53 that were required for repression of the bcl-2 promoter were defined. We conclude that the TATA sequence in the bcl-2 P2 minimal promoter is the target for repression by p53, and that the interaction between p53 and TBP is most likely responsible for the repression. Mutation of p53 may play a role in the up-regulation of bcl-2 expression in some B cell lymphomas.
引用
收藏
页码:240 / 251
页数:11
相关论文
共 50 条
  • [21] EBV, BCL-2 and p53 expression in nasopharyngeal carcinomas
    Kehrberg, EN
    Robinson, RA
    Raab, SS
    Suba, EJ
    Hoang, KX
    Le, RD
    Nguyen, DB
    LABORATORY INVESTIGATION, 1996, 74 (01) : 590 - 590
  • [22] bcl-2 and p53 protein expression in follicular lymphoma
    Cooper, K
    Haffajee, Z
    JOURNAL OF PATHOLOGY, 1997, 182 (03): : 307 - 310
  • [23] Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
    Hudie Wei
    Haolan Wang
    Genxin Wang
    Lingzhi Qu
    Longying Jiang
    Shuyan Dai
    Xiaojuan Chen
    Ye Zhang
    Zhuchu Chen
    Youjun Li
    Ming Guo
    Yongheng Chen
    Nature Communications, 14
  • [24] Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
    Wei, Hudie
    Wang, Haolan
    Wang, Genxin
    Qu, Lingzhi
    Jiang, Longying
    Dai, Shuyan
    Chen, Xiaojuan
    Zhang, Ye
    Chen, Zhuchu
    Li, Youjun
    Guo, Ming
    Chen, Yongheng
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [25] Bcl-2 expression and apoptosis in the regulation of hematopoietic stem cells
    Orelio, Claudia
    Dzierzak, Elaine
    LEUKEMIA & LYMPHOMA, 2007, 48 (01) : 16 - 24
  • [26] Detection of bcl-2 and p53 in thymoma: Expression of bcl-2 as a reliable marker of tumor aggressiveness
    Chen, FF
    Yan, JJ
    Jin, YT
    Su, IJ
    HUMAN PATHOLOGY, 1996, 27 (10) : 1089 - 1092
  • [27] Bcl-2 and p53 expression in stage I endometrial carcinoma
    Giatromanolaki, A
    Sivridis, E
    Koukourakis, MI
    Harris, AL
    Gatter, KC
    ANTICANCER RESEARCH, 1998, 18 (5B) : 3689 - 3693
  • [28] Inmunohistochemical Expression of PCNA, p53 and bcl-2 in Pleomorphic Adenomas
    Gordon-Nunez, Manuel Antonio
    Godoy, Gustavo Pina
    Soares, Rosilene Calazans
    de Souza, Lelia Batista
    Freitas, Roseana de Almeida
    Guedes Queiroz, Lelia Maria
    INTERNATIONAL JOURNAL OF MORPHOLOGY, 2008, 26 (03): : 567 - 572
  • [29] EXPRESSION OF BCL-2 AND P53 PROTEINS IN APOCRINE CARCINOMA OF THE EYELIDS
    CALZOLARI, A
    MINCIONE, F
    PUCCIONI, M
    PERLINO, P
    ALFIERI, E
    FARALDI, F
    MINCIONE, GP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S495 - S495
  • [30] p53, bcl-2, and Bax expression in renal cell carcinoma
    Vasavada, SP
    Novick, AC
    Williams, BRG
    UROLOGY, 1998, 51 (06) : 1057 - 1061